Condition
Von Willebrand Disease (VWD), Type 2
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06610201Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
NCT07273721Phase 2RecruitingPrimary
Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
NCT06754852Phase 1Recruiting
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Showing all 3 trials